McIntyre P, Blacklock Z, McCormack J G
J Infect. 1987 Jan;14(1):71-8. doi: 10.1016/s0163-4453(87)90912-1.
A case of cutaneous infection with Mycobacterium gordonae and other reports of extrapulmonary infection due to this organism are reviewed. This case confirms the pathogenic potential of M. gordonae which must now be included among the scotochromogens capable of causing cutaneous disease. Isolates of this organism should be tested against a full range of antimicrobial agents since traditional antituberculous therapy may be of limited efficacy. Pending the results of in vitro susceptibility testing, amikacin, ethambutol, rifampicin and co-trimoxazole are suggested as empirical therapy for infections caused by this organism.
回顾了1例戈登分枝杆菌皮肤感染病例以及该菌所致肺外感染的其他报道。该病例证实了戈登分枝杆菌的致病潜力，目前它必须被纳入能够引起皮肤疾病的暗产色分枝杆菌之中。由于传统抗结核治疗的疗效可能有限，应对该菌的分离株进行全面的抗菌药物测试。在体外药敏试验结果出来之前，建议使用阿米卡星、乙胺丁醇、利福平和复方新诺明作为该菌所致感染的经验性治疗药物。
